Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving people’s quality of life by preventing, alleviating and treating diseases. And we are helping to provide a reliable supply of high-quality food, feed and plant-based raw materials.
We develop new molecules for use in innovative products and solutions to improve health. Our research and development activities are based on a profound understanding of the biochemical processes in living organisms.
Our goal is to achieve and sustain leadership positions in our markets, thus creating value for our customers, stockholders and employees. To this end, our strategy is designed to help solve some of the most pressing challenges facing humankind, and by doing this exceptionally well we aim to strengthen the company’s earning power.
We are committed to operating sustainably and addressing our social and ethical responsibilities as a corporate citizen, while at the same time respecting the interests of all our stakeholders.
Revenue (FY, 2015)
Revenue growth (FY, 2014 - FY, 2015), %
Gross profit (FY, 2015)
Gross profit margin (FY, 2015), %
Net income (FY, 2015)
Market capitalization (24-Jul-2017)
Closing share price (24-Jul-2017)
|EUR||FY, 2013A||FY, 2014A||FY, 2015A|
|40.2 b||41.3 b||46.3 b|
Revenue growth, %
Cost of goods sold
|19.5 b||19.9 b||21.2 b|
|20.6 b||21.4 b||25.2 b|
Gross profit Margin, %
Sales and marketing expense
|10.3 b||10.7 b||12.4 b|
|3.4 b||3.5 b||4.3 b|
General and administrative expense
|1.7 b||1.7 b||2.1 b|
Operating expense total
|15.2 b||15.9 b||18.7 b|
Depreciation and amortization
|2.9 b||2.9 b||3.3 b|
|(1.1 b)||(1.3 b)||(1.4 b)|
|389 m||343 m||371 m|
|3.2 b||3.4 b||4.1 b|
|EUR||FY, 2013||FY, 2014||FY, 2015|
Cash From Operating Activities
|5.2 b||5.7 b||6.8 b|